SEC Form 4 · accession 0001209191-16-104084
Pediatrix Medical Group, Inc. · MD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul G Gabos
Director
Period of report
Feb 29, 2016
Accepted (ET)
Mar 1, 2016 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000893949
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 29, 2016 | M | 10,668 | $25.17 | A | 20,047 | D | |
| Common StockF1 | Feb 29, 2016 | S | 10,668 | $67.1546 | D | 9,379 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $25.17 | Feb 29, 2016 | M | 10,668 | D | May 4, 2009 | May 4, 2016 | Common Stock | 10,668 | 0 | D |
Explanation of responses
- F1Sales of shares were executed in forty (40) separate transactions with prices ranging from $66.98 to $67.34 for a weighted average sales price of $67.1546.